5 Top Biotech Stocks to Buy Now
Over the last five years, biotech stocks have trounced the performance of the S&P 500. One major reason why is the number of new drugs launched by biotech companies. More diseases than ever before can now be treated. Some of the most problematic diseases of the past can even now be cured.
The good news for investors is that it's not too late to buy several of the top biotech stocks on the market. Five of the very best are AbbVie (NYSE: ABBV), Celgene (NASDAQ: CELG), Gilead Sciences (NASDAQ: GILD), Ligand Pharmaceuticals (NASDAQ: LGND), and Vertex Pharmaceuticals (NASDAQ: VRTX). Here's why these are biotech stocks you can buy now and hold for potentially significant returns.
Image source: Getty Images.
Source: Fool.com
AbbVie Inc. Aktie
Uneingeschränkte Unterstützung für AbbVie Inc., ausschließlich Buy-Einschätzungen.
Ein leichtes Potenzial nach oben für AbbVie Inc. mit einem Kursziel von 180 € gegenüber dem aktuellen Kurs von 175.3 €.